We developed a nomogram that integrates predictive factors such as age, cancer stage, T stage, N stage, and GFPT1 expression to quantitatively assess overall survival (OS) probabilities at 1, 3, and 5 years for BRCA patients (Figure 3A). Here, GFPT1 is linked to cancer.